Bookbuilding IPO | ₹740 Cr | Listing at BSE, NSE |
G.Surgiwear Ltd. has filed a Draft Red Herring Prospectus (DRHP) with SEBI on December 30, 2025 to raise funds through Initial Public Offer (IPO).
G.Surgiwear Ltd. IPO is a Book Build Issue of ₹740.00 crores consisting of a fresh issue of shares worth Rs ₹370.00 crores and an offer for sale (OFS) of ₹370.00 crores.
The equity shares are proposed to be listed on NSE and BSE. Motilal Oswal Investment Advisors Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. Key details like IPO dates, IPO price bands and lot size are yet to be announced.
Refer to G.Surgiwear IPO DRHP for more details.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | |
| Lot Size | |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | [.] shares (agg. up to ₹740 Cr) |
| Fresh Issue | [.] shares (agg. up to ₹370 Cr) |
| Offer for Sale | [.] shares of ₹10 (agg. up to ₹370 Cr) |
| Share Holding Pre Issue | 5,41,26,560 shares |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Tue, Dec 30, 2025 |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII Shares Offered | Not less than 15% of the Offer |
Incorporated in 1990, the company designs, develops, and manufactures a wide range of surgical products and medical implantable devices. Its product portfolio includes disposable surgical drapes and dressings, hydrocephalus shunts, orthopaedic implants, bone grafting products, lumbar drainage systems, and cranial devices.
Many of its products fall under Class C and Class D medical device categories, which require strict regulatory approvals and clinical evaluations. The company’s ability to manufacture and sell these products demonstrates strong regulatory compliance.
As of September 30, 2025, the company offered 1,628 SKUs across multiple categories, including disposable drapes, dressings, cranial fixation systems, and bone cement products.
The company operates a DSIR-recognized in-house R&D center in Shahjahanpur, Uttar Pradesh. It holds 31 Indian patents and 8 international patents, and has recently launched products such as interference screws and hip prostheses.
It has an integrated manufacturing facility in Shahjahanpur, equipped with advanced and partly in-house-developed machinery. The facility is certified under WHO-GMP and multiple ISO standards, ensuring quality and scalability.
The company has a strong domestic distribution network with 36 super-stockists and 554 distributors across 23 states and union territories. Internationally, it exports to over 40 countries through 58 distributors, serving markets in Africa, South Asia, and South America.
Competitive Strengths
G. Surgiwear Ltd.'s revenue increased by 33% and profit after tax (PAT) rose by 158% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 349.10 | 324.59 | 270.88 | 211.22 |
| Total Income | 44.68 | 224.85 | 169.13 | 151.24 |
| Profit After Tax | 5.61 | 57.95 | 22.50 | 13.54 |
| EBITDA | 14.29 | 98.98 | 54.72 | 40.03 |
| NET Worth | 197.43 | 191.25 | 133.13 | 110.92 |
| Reserves and Surplus | 196.11 | 189.93 | 131.81 | 109.60 |
| Total Borrowing | 121.62 | 93.55 | 102.26 | 72.98 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Financing the capital expenditure requirements of the Company through purchase of machinery for our manufacturing facility located at Khasra No.: 771, 773, 776/1, 779/2, 777 and, 778, Village Hathaura Buzurg, Pargana and Tehsil Sadar, Shahjahanpur – 242001, Uttar Pradesh, India (“Manufacturing Facility”) | 167.22 |
| 2 | Pre-payment/ re-payment, in part or full, of certain outstanding borrowings availed by our Company; and | 93.64 |
| 3 | General corporate purposes |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 30.30% |
| ROCE | 29.66% |
| Debt/Equity | 0.49 |
| RoNW | 30.30% |
| PAT Margin | 25.77% |
| EBITDA Margin | 44.19% |
| Pre IPO | Post IPO | |
|---|---|---|
| Promoter Holding | 92.96% |
Lead Manager Reports
G.Surgiwear IPO is a main-board IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹740 Crores. The issue is priced at To be declared. The minimum order quantity is .
The G.Surgiwear IPO open and close dates are not available as of now.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in G.Surgiwear IPO using UPI as a payment gateway. Zerodha customers can apply in G.Surgiwear IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in G.Surgiwear IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The G.Surgiwear IPO dates are not announced. Please check back again after some time.
G.Surgiwear IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in G.Surgiwear IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for G.Surgiwear IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the G.Surgiwear IPO allotment status.
The G.Surgiwear IPO listing date is not yet announced. The tentative date of listing is .
